Search Results - "Berk, Velı"

Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology–oncology patients by Demiraslan, Hayati, Sevim, Mustafa, Pala, Çiğdem, Durmaz, Süleyman, Berk, Veli, Kaynar, Leylagül, Metan, Gökhan

“…Stenotrophomonas maltophilia infection is of concern in patients with cancer. Antibiotics active against S. maltophilia are rarely used in the treatment of…”
Get full text

Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients by Duran, Ayse Ocak, Inanc, Mevlude, Karaca, Halit, Dogan, Imran, Berk, Veli, Bozkurt, Oktay, Ozaslan, Ersin, Ucar, Mahmut, Eroglu, Celalettin, Ozkan, Metin

“…Prior studies showed a relationship between serum albumin and the albumin to globulin ratio with different types of cancer. We aimed to evaluate the predictive…”
Get full text

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer by Inanc, Mevlude, Ozkan, Metin, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Duran, Ayse Ocak, Ozaslan, Ersin, Akgun, Hulya, Tekelioglu, Fatos, Elmali, Ferhan

“…In subgroups of breast cancer, the shortest disease-free and overall survival was observed in basaloid and human epidermal growth factor receptor-2 groups…”
Get full text

Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer by Mutlu, Hasan, Berk, Veli, Karaca, Halit, Erden, Abdülsamet, Aslan, Tuncay, Akca, Zeki

“…The risk of thromboemboli is increased in patients with cancer, and this is precipitated by the chemotherapeutic agents. Bevacizumab is an anti-vascular…”
Get more information

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology by Berk, Veli, Kaplan, Mehmet Ali, Tonyali, Onder, Buyukberber, Suleyman, Balakan, Ozan, Ozkan, Metin, Demirci, Umut, Ozturk, Turkan, Bilici, Ahmet, Tastekin, Didem, Ozdemir, Nuriye, Unal, Olcun Umit, Oflazoglu, Utku, Turkmen, Esma, Erdogan, Bulent, Uyeturk, Ummugul, Oksuzoglu, Berna, Cinkir, Havva Yesil, Yasar, Nurgul, Gumus, Mahmut

“…Inoperable and metastatic hepatocellular carcinoma (HCC) is associated with a poor prognosis and low chemotherapeutic efficiency. Sorafenib is an oral…”
Get full text

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer by Bozkurt, Oktay, Inanc, Mevlude, Turkmen, Esma, Karaca, Halit, Berk, Veli, Duran, Ayse Ocak, Ozaslan, Ersin, Ucar, Mahmut, Hacibekiroglu, Ilhan, Eker, Baki, Baspinar, Osman, Ozkan, Metin

“…To investigate clinicopathological features in patients with recurrent colorectal cancer within 1 year and more than 1 year after curative resection. We…”
Get full text

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? by Bozkurt, Oktay, Hacıbekiroglu, Ilhan, Kaplan, Muhammet Ali, Duzkopru, Yakup, Uysal, Mukremin, Karaca, Halit, Berk, Veli, Inanc, Mevlude, Duran, Ayse Ocak, Ozaslan, Ersin, Ucar, Mahmut, Ozkan, Metin

“…Micro-Abstract Although there has been an increase in overall and progression-free survival with the use of novel targeted therapies in metastatic renal cell…”
Get full text

Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor by Cetin, Bulent, Kaplan, Mehmet Ali, Berk, Veli, Tufan, Gulnihal, Benekli, Mustafa, Isikdogan, Abdurrahman, Ozkan, Metin, Coskun, Ugur, Buyukberber, Suleyman

“…Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns…”
Get full text

Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in GEP-NETs by Berk, Veli, Ozaslan, Ersin

“…Abstract only…”
Get full text

Protective effects of spironolactone against anthracycline-induced cardiomyopathy by Akpek, Mahmut, Ozdogru, Ibrahim, Sahin, Omer, Inanc, Mevlude, Dogan, Ali, Yazici, Cevat, Berk, Veli, Karaca, Halit, Kalay, Nihat, Oguzhan, Abdurrahman, Ergin, Ali

“…Aims The protective effect of beta‐blockers, ACE inhibitors, and ARBs on anthracycline cardiotoxicity has already been demonstrated, but the effect of…”
Get full text

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study by Kaya, Mehmet G, Ozkan, Metin, Gunebakmaz, Ozgur, Akkaya, Hasan, Kaya, Esma G, Akpek, Mahmut, Kalay, Nihat, Dikilitas, Mustafa, Yarlioglues, Mikail, Karaca, Halit, Berk, Veli, Ardic, Idris, Ergin, Ali, Lam, Yat Yin

“…Abstract Background We aimed to evaluate the effect of prophylactic nebivolol use on prevention of antracycline-induced cardiotoxicity in breast cancer…”
Get full text

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study by Olmez, Omer Fatih, Bilici, Ahmet, Er, Ozlem, Bisgin, Atil, Sevinc, Alper, Akman, Tulay, Uslu, Ruchan, Mandel, Nil Molinas, Yalcin, Suayib, Teomete, Mehmet, Gorumlu, Gurbuz, Demir, Atakan, Namal, Esat, Alici, Suleyman, Selcukbiricik, Fatih, Bavbek, Sevil, Paksoy, Fatma, Basaran, Gul, Ozer, Leyla, Sener, Nur, Harputluoglu, Hakan

“…The objective of this multi-centre, real-world study was to examine the potential influence of comprehensive molecular profiling on the development of…”
Get full text

The effect of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy by Karaca, Halit, Berk, Veli, Inanc, Mevlude, Dikilitas, Mustafa, Ozkan, Metin

“…Abstract only e20603 Background: β-glucans have antibacterial, immunomodulator and anti-cancer effects. The present study aimed to determine the effect of oral…”
Get full text

Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab by Berk, Veli, Deniz, Kemal, Bozkurt, Oktay, Ozaslan, Ersin, Karaca, Halit, Inanc, Mevlude, Duran, Ayse Ocak, Ozkan, Metin

Get full text

Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients by Bozkurt, Oktay, Karaca, Halit, Berk, Veli, Inanc, Mevlude, Ocak Duran, Ayse, Ozaslan, Ersin, Ucar, Mahmut, Ozkan, Metin

“…Increasing evidence supports an association between systemic inflammation and cancer development and progression. The neutrophil to lymphocyte ratio (NLR) is…”
Get more information

Salvage Chemotherapy with Weekly Paclitaxel for Metastatic Melanoma by Ozaslan, Ersin, Aksoy, Asude, Gumusay, Ozge, Arpaci, Erkan, Berk, Veli

Get full text

The association of human epidermal growth factor receptor-2 (HER-2) expression with clinicopathologic findings in patients with colorectal cancer receiving adjuvant therapy by Karaca, Halit, Berk, Veli, Inanc, Mevlude, Deniz, Kemal, Ozkan, Metin

“…Abstract only e14089 Background: Colorectal cancers (CRC) are the third frequent cancer worldwide. Like in other cancers; factors which might be associated…”
Get full text

Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients by Eker, Baki, Ozaslan, Ersin, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Inanc, Mevlude, Duran, Ayse Ocak, Ozkan, Metin

Get full text

Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy by Inanc, Mevlude, Duran, Ayse Ocak, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Ozaslan, Ersin, Ozkan, Metin

“…The standard treatment in the metastatic colorectal cancer consists of 5-FU based infusional regimens. However, with oral fluoropyrimidines, equal tumor…”
Get full text

Predictive significance of VEGF and HIF-1α expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab by Berk, Veli, Deniz, Kemal, Karaca, Halit, Inanc, Mevlude, Bozkurt, Oktay, Duran, Ayse Ocak, Ozkan, Metin

“…Abstract only e14672 Background: There is no suggested molecular indicator in identifying which patients will benefit from anti-angiogenic treatment in…”
Get full text